BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 31, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2019
View Archived Issues
Another reason to vaccinate
Read More
Motor scores mislead in Parkinson's disease model
Read More
Lipac Oncology advances evaluation of TBC-1002 in bladder cancer
Read More
Mutant mouse with seizures, tremor and increased levels of neurotransmitters as an epilepsy model
Read More
Selective Nav1.7 inhibitor shows analgesic efficacy in pain mouse models
Read More
BioCryst advances phase I study of BCX-9930 for paroxysmal nocturnal hemoglobinuria
Read More
Heterozygous p.Leu47Val variant in HSPD1 causes hypomyelinating leukodystrophy
Read More
First subject dosed in phase II ADVISE study of etrasimod in atopic dermatitis
Read More
Interim results presented from pivotal phase III SIERRA study of Iomab-B in AML
Read More
Microbion announces phase Ib data for pravibismane in infected diabetic foot ulcers
Read More
MyoKardia announces promising results from phase IIa study of MYK-491
Read More
Autophagy defects caused by TRAPPC4 variant are associated with syndromic intellectual disability
Read More
First known case of jaw keratocyst in an individual with SUFU-related Gorlin syndrome
Read More
Phase II results presented for TIMP-GLIA in celiac disease
Read More
University of Texas System patents CBP and KAT3B inhibitors
Read More
Pivotal study of budesonide oral suspension in eosinophilic esophagitis achieves endpoints
Read More
Iveric Bio's phase IIb study of Zimura for geographic atrophy in dry AMD meets primary endpoint
Read More
TG reports promising data from phase II UNITY-NHL trial of umbralisib in follicular lymphoma
Read More
BioCryst Pharmaceuticals discloses complement factor D inhibitors
Read More
GlaxoSmithKline identifies new ATF-4 inhibitors
Read More
Flex Pharma synthesizes voltage-gated sodium channel blockers
Read More
New adenosine A2A receptor antagonists disclosed by BeiGene
Read More
Ziopharm and MD Anderson agree to expand TCR-T program
Read More
European Commission approves Bavencio with axitinib for first-line advanced RCC
Read More
AstraZeneca reports promising PFS data with Imfinzi and tremelimumab in stage IV NSCLC
Read More
CARB-X award supports BioVersys' development of antimicrobial therapies
Read More
At Molecular Targets meeting, a bonanza of ways to thwart "undruggable" KRAS
Read More
Clinical development of MOR-106 for atopic dermatitis ended for futility
Read More
